Global Injectable Anthelmintic Drugs Market Insights, Forecast to 2028

Report ID: 1752055 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Benzimidazoles
        1.2.3 Piperazine
        1.2.4 Imidazothiazole
        1.2.5 Spiroindoles
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
        1.3.5 Veterinary Pharmacies
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Injectable Anthelmintic Drugs Market Perspective (2017-2028)
    2.2 Injectable Anthelmintic Drugs Growth Trends by Region
        2.2.1 Injectable Anthelmintic Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Injectable Anthelmintic Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Injectable Anthelmintic Drugs Market Dynamics
        2.3.1 Injectable Anthelmintic Drugs Industry Trends
        2.3.2 Injectable Anthelmintic Drugs Market Drivers
        2.3.3 Injectable Anthelmintic Drugs Market Challenges
        2.3.4 Injectable Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Injectable Anthelmintic Drugs Players by Revenue
        3.1.1 Global Top Injectable Anthelmintic Drugs Players by Revenue (2017-2022)
        3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Injectable Anthelmintic Drugs Revenue
    3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio
        3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2021
    3.5 Injectable Anthelmintic Drugs Key Players Head office and Area Served
    3.6 Key Players Injectable Anthelmintic Drugs Product Solution and Service
    3.7 Date of Enter into Injectable Anthelmintic Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Anthelmintic Drugs Breakdown Data by Type
    4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2023-2028)
5 Injectable Anthelmintic Drugs Breakdown Data by Application
    5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Injectable Anthelmintic Drugs Market Size (2017-2028)
    6.2 North America Injectable Anthelmintic Drugs Market Size by Type
        6.2.1 North America Injectable Anthelmintic Drugs Market Size by Type (2017-2022)
        6.2.2 North America Injectable Anthelmintic Drugs Market Size by Type (2023-2028)
        6.2.3 North America Injectable Anthelmintic Drugs Market Share by Type (2017-2028)
    6.3 North America Injectable Anthelmintic Drugs Market Size by Application
        6.3.1 North America Injectable Anthelmintic Drugs Market Size by Application (2017-2022)
        6.3.2 North America Injectable Anthelmintic Drugs Market Size by Application (2023-2028)
        6.3.3 North America Injectable Anthelmintic Drugs Market Share by Application (2017-2028)
    6.4 North America Injectable Anthelmintic Drugs Market Size by Country
        6.4.1 North America Injectable Anthelmintic Drugs Market Size by Country (2017-2022)
        6.4.2 North America Injectable Anthelmintic Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Injectable Anthelmintic Drugs Market Size (2017-2028)
    7.2 Europe Injectable Anthelmintic Drugs Market Size by Type
        7.2.1 Europe Injectable Anthelmintic Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Injectable Anthelmintic Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Injectable Anthelmintic Drugs Market Share by Type (2017-2028)
    7.3 Europe Injectable Anthelmintic Drugs Market Size by Application
        7.3.1 Europe Injectable Anthelmintic Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Injectable Anthelmintic Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Injectable Anthelmintic Drugs Market Share by Application (2017-2028)
    7.4 Europe Injectable Anthelmintic Drugs Market Size by Country
        7.4.1 Europe Injectable Anthelmintic Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Injectable Anthelmintic Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type
        8.2.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Injectable Anthelmintic Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application
        8.3.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Injectable Anthelmintic Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region
        8.4.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Injectable Anthelmintic Drugs Market Size (2017-2028)
    9.2 Latin America Injectable Anthelmintic Drugs Market Size by Type
        9.2.1 Latin America Injectable Anthelmintic Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Injectable Anthelmintic Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Injectable Anthelmintic Drugs Market Share by Type (2017-2028)
    9.3 Latin America Injectable Anthelmintic Drugs Market Size by Application
        9.3.1 Latin America Injectable Anthelmintic Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Injectable Anthelmintic Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Injectable Anthelmintic Drugs Market Share by Application (2017-2028)
    9.4 Latin America Injectable Anthelmintic Drugs Market Size by Country
        9.4.1 Latin America Injectable Anthelmintic Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Injectable Anthelmintic Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type
        10.2.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Injectable Anthelmintic Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application
        10.3.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Injectable Anthelmintic Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country
        10.4.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Details
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Injectable Anthelmintic Drugs Introduction
        11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.1.5 Novartis Recent Developments
    11.2 Cipla
        11.2.1 Cipla Company Details
        11.2.2 Cipla Business Overview
        11.2.3 Cipla Injectable Anthelmintic Drugs Introduction
        11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.2.5 Cipla Recent Developments
    11.3 Sun Pharmaceutical Industries
        11.3.1 Sun Pharmaceutical Industries Company Details
        11.3.2 Sun Pharmaceutical Industries Business Overview
        11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction
        11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.3.5 Sun Pharmaceutical Industries Recent Developments
    11.4 Amneal Pharmaceuticals
        11.4.1 Amneal Pharmaceuticals Company Details
        11.4.2 Amneal Pharmaceuticals Business Overview
        11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction
        11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.4.5 Amneal Pharmaceuticals Recent Developments
    11.5 Zoetis
        11.5.1 Zoetis Company Details
        11.5.2 Zoetis Business Overview
        11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction
        11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.5.5 Zoetis Recent Developments
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Details
        11.6.2 GlaxoSmithKline Business Overview
        11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction
        11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.6.5 GlaxoSmithKline Recent Developments
    11.7 Bayer
        11.7.1 Bayer Company Details
        11.7.2 Bayer Business Overview
        11.7.3 Bayer Injectable Anthelmintic Drugs Introduction
        11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.7.5 Bayer Recent Developments
    11.8 Merck
        11.8.1 Merck Company Details
        11.8.2 Merck Business Overview
        11.8.3 Merck Injectable Anthelmintic Drugs Introduction
        11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.8.5 Merck Recent Developments
    11.9 Boehringer Ingelheim International
        11.9.1 Boehringer Ingelheim International Company Details
        11.9.2 Boehringer Ingelheim International Business Overview
        11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction
        11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2017-2022)
        11.9.5 Boehringer Ingelheim International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Benzimidazoles
    Table 3. Key Players of Piperazine
    Table 4. Key Players of Imidazothiazole
    Table 5. Key Players of Spiroindoles
    Table 6. Key Players of Others
    Table 7. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Injectable Anthelmintic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Injectable Anthelmintic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Injectable Anthelmintic Drugs Market Share by Region (2017-2022)
    Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Injectable Anthelmintic Drugs Market Share by Region (2023-2028)
    Table 13. Injectable Anthelmintic Drugs Market Trends
    Table 14. Injectable Anthelmintic Drugs Market Drivers
    Table 15. Injectable Anthelmintic Drugs Market Challenges
    Table 16. Injectable Anthelmintic Drugs Market Restraints
    Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Injectable Anthelmintic Drugs Revenue Share by Players (2017-2022)
    Table 19. Global Top Injectable Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2021)
    Table 20. Ranking of Global Top Injectable Anthelmintic Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Injectable Anthelmintic Drugs Product Solution and Service
    Table 24. Date of Enter into Injectable Anthelmintic Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Injectable Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Injectable Anthelmintic Drugs Revenue Share by Application (2017-2022)
    Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Injectable Anthelmintic Drugs Revenue Share by Application (2023-2028)
    Table 34. North America Injectable Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Injectable Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Injectable Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Injectable Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Injectable Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Injectable Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Injectable Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Injectable Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Injectable Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Injectable Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Injectable Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Injectable Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Injectable Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Injectable Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Injectable Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Injectable Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Injectable Anthelmintic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Injectable Anthelmintic Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Injectable Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Injectable Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Injectable Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Injectable Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Injectable Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Injectable Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Injectable Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Injectable Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Injectable Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Injectable Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Injectable Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Injectable Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Novartis Company Details
    Table 65. Novartis Business Overview
    Table 66. Novartis Injectable Anthelmintic Drugs Product
    Table 67. Novartis Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 68. Novartis Recent Developments
    Table 69. Cipla Company Details
    Table 70. Cipla Business Overview
    Table 71. Cipla Injectable Anthelmintic Drugs Product
    Table 72. Cipla Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 73. Cipla Recent Developments
    Table 74. Sun Pharmaceutical Industries Company Details
    Table 75. Sun Pharmaceutical Industries Business Overview
    Table 76. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product
    Table 77. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 78. Sun Pharmaceutical Industries Recent Developments
    Table 79. Amneal Pharmaceuticals Company Details
    Table 80. Amneal Pharmaceuticals Business Overview
    Table 81. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product
    Table 82. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 83. Amneal Pharmaceuticals Recent Developments
    Table 84. Zoetis Company Details
    Table 85. Zoetis Business Overview
    Table 86. Zoetis Injectable Anthelmintic Drugs Product
    Table 87. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 88. Zoetis Recent Developments
    Table 89. GlaxoSmithKline Company Details
    Table 90. GlaxoSmithKline Business Overview
    Table 91. GlaxoSmithKline Injectable Anthelmintic Drugs Product
    Table 92. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 93. GlaxoSmithKline Recent Developments
    Table 94. Bayer Company Details
    Table 95. Bayer Business Overview
    Table 96. Bayer Injectable Anthelmintic Drugs Product
    Table 97. Bayer Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 98. Bayer Recent Developments
    Table 99. Merck Company Details
    Table 100. Merck Business Overview
    Table 101. Merck Injectable Anthelmintic Drugs Product
    Table 102. Merck Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 103. Merck Recent Developments
    Table 104. Boehringer Ingelheim International Company Details
    Table 105. Boehringer Ingelheim International Business Overview
    Table 106. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product
    Table 107. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 108. Boehringer Ingelheim International Recent Developments
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Injectable Anthelmintic Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Benzimidazoles Features
    Figure 3. Piperazine Features
    Figure 4. Imidazothiazole Features
    Figure 5. Spiroindoles Features
    Figure 6. Others Features
    Figure 7. Global Injectable Anthelmintic Drugs Market Share by Application: 2021 VS 2028
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Veterinary Pharmacies Case Studies
    Figure 12. Others Case Studies
    Figure 13. Injectable Anthelmintic Drugs Report Years Considered
    Figure 14. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Injectable Anthelmintic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Injectable Anthelmintic Drugs Market Share by Region: 2021 VS 2028
    Figure 17. Global Injectable Anthelmintic Drugs Market Share by Players in 2021
    Figure 18. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2021
    Figure 20. North America Injectable Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Injectable Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 22. North America Injectable Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 23. North America Injectable Anthelmintic Drugs Market Size Share by Country (2017-2028)
    Figure 24. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Injectable Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Injectable Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Injectable Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Injectable Anthelmintic Drugs Market Size Share by Country (2017-2028)
    Figure 30. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Injectable Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Injectable Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Injectable Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Injectable Anthelmintic Drugs Market Size Share by Region (2017-2028)
    Figure 40. China Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Injectable Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Injectable Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Injectable Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Injectable Anthelmintic Drugs Market Size Share by Country (2017-2028)
    Figure 50. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Injectable Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Injectable Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Injectable Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Injectable Anthelmintic Drugs Market Size Share by Country (2017-2028)
    Figure 56. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Injectable Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 60. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 61. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 62. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 63. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 64. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 65. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 66. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 67. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International
Frequently Asked Questions
Injectable Anthelmintic Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Injectable Anthelmintic Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Injectable Anthelmintic Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports